secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acadia Healthcare Company, Inc. (ACHC)
CIK:        0001520697
Form:       8-K
Filed at:   2022-04-04T23:59:59+00:00
Accession:  0001157523-22-000389
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acadia Healthcare appoints Christopher Hunter as new CEO, effective April 11, 2022
--------------------------------------------------------------------------------

- Christopher Hunter named CEO and director; effective April 11, 2022; previously at Humana, TriZetto, BlueCross BlueShield.
- CEO compensation: $1M base salary, 100% target bonus (max 200%), $1M RSUs (4-yr vest), $3.5M PSUs (target, 2022-2024).
- Debbie Osteen to provide transition advisory services for $20,000/month; remains on Acadia Board.
- Board expanded from 9 to 10 directors to accommodate Hunter's appointment.
- Severance: 1.5x (salary+target) for non-CIC without cause/good reason; 2x for CIC; equity vesting provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520697/000115752322000389/0001157523-22-000389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520697/000115752322000389/a52644158.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-000389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer